World Sepsis Day, observed annually on 13 September, aims to raise awareness about sepsis, a life-threatening condition that ...

Alchemab Therapeutics has appointed Jane Osbourn, the company’s Co-Founder and Chief Scientific Officer, as Chief Executive ...

The conference will return to Vienna AirportCity on 23 to 24 October 2024 Samedan has announced that on 23 to 24 October 2024, its FlyPharma Conference will make a welcome return to Office Park 4, ...

The centre aims to discover new drug targets for diseases such as Parkinson’s and hypertension The UK Research and Innovation’s (UKRI) Medical Research Council (MRC) has awarded £27.4m to a University ...

The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex The World Health Organization (WHO) has announced that it has added Bavarian Nordic’s mpox vaccine to its list of ...

Leeds Teaching Hospitals NHS Trust (LTHT) has announced that it is piloting a new artificial intelligence (AI) and machine learning software system for prostate cancer diagnosis. Working in ...

Chemistry is the cornerstone of modern civilisation, playing a crucial role in virtually every aspect of our lives. From the food we eat and the water we drink to the medicines which save lives and ...

The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley as Acting President. Abberley, who is General Manager of Amgen UK and Ireland, has over 25 years of life ...

This month’s PharmaTimes is packed with a variety of features centred on clinical research, the lifeblood of our industry. Our insightful front cover article delves into the key regulatory ...

New evidence highlights AI’s potential in early lung cancer detection At the IASLC 2024 World Conference on Lung Cancer in San Diego, a new study has demonstrated that AI-powered chest X-ray ...

Acelyrin has shared positive results from a late-stage study of its IL-17A inhibitor izokibep in hidradenitis suppurativa (HS), but has said it will not be moving forward with the asset in this ...